Multimodal Treatment of Rectal Cancer: How Robotic Surgery Enhances Outcomes

Rectal cancer is the third most common cancer in the digestive system, behind colon cancer and pancreatic cancer. It is possible to have rectal cancer for years without noticing changes in your body. In many cases, rectal cancers don’t cause symptoms at all. However, some people may notice certain warning signs. Warning signs of rectal cancer include persistent changes in bowel habits (diarrhoea, constipation, narrow stools), rectal bleeding (bright red or dark blood in stool/on paper), a feeling of incomplete bowel emptying, abdominal discomfort (cramps, gas, pain), unexplained weight loss, fatigue, and weakness, though early stages might have no symptoms, making regular screening crucial. 

Understanding Rectal Cancer 

Rectal cancer is cancer that forms in the tissues of the rectum, the last section of the large intestine. The rectum forms the end of the large intestine and opens into the anus.

Rectal cancer starts when abnormal cells grow in the rectum (the end of the large intestine), often from polyps, forming tumours that can spread, and is grouped with colon cancer as colorectal cancer, but treated uniquely due to the rectum’s confined location. Cancer begins as cells in the rectal lining and grows uncontrollably, often starting as benign growths (polyps) that can turn malignant.

Rectal cancer complications include severe bleeding. Chronic blood loss leading to iron deficiency and anaemia, sometimes severe enough for circulation failure. It can even be an intestinal obstruction, with tumor growth blocking the bowel, preventing stool passage. It is sometimes possible that there is a tear in the intestine, requiring emergency surgery. In some patients, there can be metastasis (spread to distant organs like the liver, lungs, bones, and brain).

Early detection via screening is crucial, as it’s often curable with treatments like surgery, radiation, and chemotherapy, depending on the stage. 

Treatment

Rectal cancer treatment involves a multi-modal approach, primarily using surgery to remove the tumor, often combined with chemotherapy, radiation therapy, or chemoradiation (neoadjuvant or adjuvant) to shrink tumors or kill remaining cells, with newer options like targeted therapy and immunotherapy also available, depending on cancer stage, location, and patient health. 

Key Treatment Modalities:

1. Surgery: The main curative treatment, removing cancerous sections of the rectum and nearby lymph nodes. Procedures include:

• Low Anterior Resection (LAR): Removes part of the rectum, connecting the colon to the remaining rectum or anus.
• Abdominoperineal Resection (APR) Removes the rectum, anus, and surrounding tissue, requiring a permanent colostomy (stoma).

2. Radiation Therapy: Uses high-energy beams to destroy cancer cells, often given before surgery (neoadjuvant) to shrink tumors or after (adjuvant) to prevent recurrence.
3. Chemotherapy: Drug therapy to kill fast-growing cancer cells, used with radiation or after surgery to reduce recurrence risk.
4. Chemoradiation: Combines chemotherapy and radiation, a common approach for rectal cancer.
5. Targeted Therapy & Immunotherapy: Newer drug treatments that target specific cancer cells or boost the immune system, used in certain cases, especially if cancer has spread. 

Multimodal treatment for rectal cancer combines multiple therapies, primarily surgery, chemotherapy, and radiation, often given in sequence (neoadjuvant/adjuvant) to shrink tumors, kill cancer cells, prevent recurrence, and manage metastases, aiming for better outcomes through an integrated approach guided by specialists, using advanced imaging like MRI to personalize plans and potentially spare surgery in some cases. 

Robotic Surgery for Rectal Cancer 

Robotic surgery for rectal cancer uses systems like da Vinci to give surgeons magnified 3D vision and precise, tremor-filtered instruments for complex pelvic dissections, potentially reducing blood loss, improving nerve preservation (improving sexual/urinary function), and shortening hospital stays compared to open surgery. 

The surgeon sits at a console, viewing a magnified 3D image and controlling robotic arms with foot pedals and hand controls. Robotic arms hold miniaturized instruments with greater dexterity (wrist-like motion) than human hands, allowing precise movement in tight pelvic spaces. High-definition cameras and tremor filtering enhance visualization and stability, crucial for delicate nerve bundles near the rectum. 

How Does Robotic Surgery Enhance Outcomes? 

Robotic systems provide magnified, immersive 3D views and instruments with greater articulation, allowing surgeons to meticulously dissect and preserve delicate nerves crucial for function. Better nerve preservation often leads to quicker recovery of bladder and sexual function post-surgery. Studies show potential for higher complete tumor resection rates (TME) and improved relapse-free survival, especially in complex or lower rectal tumors. Lower rates of blood loss, infection, and shorter hospital stays are reported compared to open surgery. Comfortable seated operating position reduces surgeon fatigue, improving focus and performance.  However, it is to be noted that robotic surgery generally involves longer operative times and significantly higher costs than laparoscopic or open surgery. 

Conclusion

Multimodal treatment leverages different modalities (radiation, chemo, surgery) synergistically, offering superior oncologic control and functional outcomes compared to surgery alone, especially for challenging, locally advanced rectal cancers. Robotic-assisted surgery is a powerful tool, especially for challenging rectal cancer cases, offering significant functional and oncological advantages, but its high cost remains a key factor in its widespread adoption. 

Frequently Asked Questions